[[Mark Fishman]]

CATEGORIES: Living people, American scientists, American medical researchers, American cardiologists, Businesspeople in the pharmaceutical industry, American business executives, Year of birth missing (living people), American businesspeople, Yale University alumni, Harvard Medical School alumni, Harvard Medical School faculty

Mark Fishman is a noted researcher and clinician in cardiology and the current President of the Novartis Institutes for BioMedical Research (NIBR),http://www.novartis.com/about-novartis/people/executive-committee.shtml the main research arm of Novartis Pharmaceuticals with over 6,700 employees and a 2012 budget of more than $9B.http://www.novartis.com/newsroom/fact-sheet.shtml
Fishman was appointed President of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort.http://www.prdomain.com/companies/N/Novartis/newsreleases/20025718532.htm  He is the author of over 100 publicationshttp://www.pubmed.gov 183 results as of 20 Oct 2009 and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.http://physiolgenomics.physiology.org/cgi/content/full/2/2/49http://people.forbes.com/profile/mark-c-fishman/58785http://www.baderc.org/bios/FishmanBios.pdf

==Education==

==Career==

He was previously a Professor of Medicine at Harvard Medical School, Chief of Cardiology at Massachusetts General Hospital, and director of the Cardiovascular Research Center at Massachusetts General Hospital.  He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine.http://www.novartis.com/downloads/newsroom/corporate-press-kit/7g_CV_Mark_C_Fishman_EN.pdf

==References==

==External links==


